Slingshot Insights

Catalyst

Slingshot members are tracking this event:

FDA approves Endo International(ENDP) chronic pain drug Belbuca

Source Link:: http://finance.yahoo.com/news/biodelivery-endo-fda-approval-pain-183906873.html

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies

Importance

High

Medium

Low

Impact on Stocks

BDSI

100%

ENDP

100%

SIGN ME UP
I want to vote! LOG ME IN
Now!

Additional Information

Additional Relevant Details The FDA has approved Endo International's chronic pain treatment Belbuca. Endo is partnered with Biodelivery to develop Belbuca. With the approval of Belbuca Endo has to pay a $50 milion milestone payment to Biodelivery.

http://finance.yahoo...

Slingshot Insights Explained

JOIN FOR FREE TODAY

Catalyst Date

Occurred on:

Oct 27, 2015

Related Projects

Don’t see a project related to the catalyst you care about?

Related Keywords Belbuca, Chronic Pain Management